相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population
Dimitrios Farmakis et al.
EUROPEAN HEART JOURNAL (2020)
Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology*
Massimo F. Piepoli et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Short-term biological variation and diurnal rhythm of cardiac troponin I (Access hs-TnI) in healthy subjects
Martina Zaninotto et al.
CLINICA CHIMICA ACTA (2020)
High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population
Dimitrios Farmakis et al.
EUROPEAN HEART JOURNAL (2020)
Cardiac troponins as biomarkers for cardiac disease
Claudio Passino et al.
BIOMARKERS IN MEDICINE (2019)
Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trondelag Health Study
Magnus N. Lyngbakken et al.
CLINICAL CHEMISTRY (2019)
High-sensitivity troponin I for cardiovascular risk stratification in the general asymptomatic population: Perspectives from Asia-Pacific
Carolyn S. P. Lam et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study
Xiaoming Jia et al.
CIRCULATION (2019)
Cardiac Troponin T and Troponin I in the General Population Comparing and Contrasting Their Genetic Determinants and Associations With Outcomes
Paul Welsh et al.
CIRCULATION (2019)
Evaluation of reproducibility of the cTnT immunoassay using quality control samples
Rudina Ndreu et al.
CLINICA CHIMICA ACTA (2019)
Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: A multi-center study
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2019)
Response by du Fay de Lavallaz et al to Letter Regarding Article, B-Type Natriuretic Peptides and Cardiac Troponins for Diagnosis and Risk-Stratification of Syncope
Jeanne du Fay de Lavallaz et al.
CIRCULATION (2019)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (vol 140, e596, 2019)
Donna K. Arnett et al.
CIRCULATION (2019)
High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australian population-based cohort
Kun Zhu et al.
HEART (2018)
Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trondelag Health [HUNT] Study)
Fjola D. Sigurdardottir et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine
Alan H. B. Wu et al.
CLINICAL CHEMISTRY (2018)
Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin I
Veronica Musetti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I
Silvia Masotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Evaluation of analytical performance of a chemiluminescence enzyme immunoassay (CLEIA) for cTnI using the automated AIA-CL2400 platform
Silvia Masotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
The paradox of low B-type natriuretic peptide levels in obesity revisited: does sex matter?
Aldo Clerico et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort
Paul Welsh et al.
CLINICAL CHEMISTRY (2018)
Future biomarkers in cardiology: my favourites
Arthur Mark Richards
EUROPEAN HEART JOURNAL SUPPLEMENTS (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension ESC/ESH Task Force for the Management of Arterial Hypertension
Bryan Williams et al.
JOURNAL OF HYPERTENSION (2018)
How is cardiac troponin released from injured myocardium?
Johannes Mair et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
Association of Repeatedly Measured High-Sensitivity Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study
Maria F. Hughes et al.
CLINICAL CHEMISTRY (2017)
Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care
Fred S. Apple et al.
CLINICAL CHEMISTRY (2017)
Variability of biomarkers in patients with chronic heart failure and healthy controls
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus
Michael J. Zellweger et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Multiple health behaviour change interventions for primary prevention of cardiovascular disease in primary care: systematic review and meta-analysis
Samah Alageel et al.
BMJ OPEN (2017)
Circadian rhythm of blood cardiac troponin T concentration
Stephane Fournier et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Twenty-Four-Hour Biological Variation Profiles of Cardiac Troponin I in Individuals with or without Chronic Kidney Disease
Noreen van der Linden et al.
CLINICAL CHEMISTRY (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
High-sensitivity Troponin T Assay in Asymptomatic High Cardiovascular Risk Patients. The TUSARC Registry
Isabel Alvarez et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2017)
Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium
Jack Marjot et al.
CLINICAL CHEMISTRY (2017)
Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender
Piercarlo Ballo et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals
Ingunn Thorsteinsdottir et al.
CLINICAL CHEMISTRY (2016)
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
Stefan Blankenberg et al.
EUROPEAN HEART JOURNAL (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations - A Systematic Review and Meta-analysis
Julie Sze et al.
HEART LUNG AND CIRCULATION (2016)
Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population A meta-analysis
Noreen van der Linden et al.
MEDICINE (2016)
Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy
Stefanie Hasler et al.
SWISS MEDICAL WEEKLY (2016)
The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS)
Bernhard Rauch et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Comparison of conventional and high-sensitivity troponin in patients with chest pain: A collaborative meta-analysis
Michael J. Lipinski et al.
AMERICAN HEART JOURNAL (2015)
Diagnostic utility of BNP, corin and furin as biomarkers for cardiovascular complications in type 2 diabetes mellitus patients
Shadia A. Fathy et al.
BIOMARKERS (2015)
High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention Impact of Statin Therapy
Brendan M. Everett et al.
CIRCULATION (2015)
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy
Maria Franzini et al.
CLINICA CHIMICA ACTA (2015)
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2015)
Impact of Sex on the Prognostic Value of High-Sensitivity Cardiac Troponin I in the General Population: The HUNT Study
Torbjorn Omland et al.
CLINICAL CHEMISTRY (2015)
The war against heart failure: the Lancet lecture
Eugene Braunwald
LANCET (2015)
Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients
Alaa A. Shalaby et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2015)
Effectiveness of multifactorial interventions in primary health care settings for primary prevention of cardiovascular disease: A systematic review of systematic reviews
Celia Alvarez-Bueno et al.
PREVENTIVE MEDICINE (2015)
Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease
Chunfang Ju et al.
MEDICAL SCIENCE MONITOR (2015)
The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk
S. Masson et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Higher Serum Concentrations of N-Terminal Pro-B-Type Natriuretic Peptide Associate with Prevalent Hypertension whereas Lower Associate with Incident Hypertension
Ekim Seven et al.
PLOS ONE (2015)
Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome A Systematic Review and Meta-analysis
Erin D. Michos et al.
ANNALS OF INTERNAL MEDICINE (2014)
Weekly and 90-Minute Biological Variations in Cardiac Troponin T and Cardiac Troponin I in Hemodialysis Patients and Healthy Controls
Kristin M. Aakre et al.
CLINICAL CHEMISTRY (2014)
The role of cardiac biomarkers in cardiovascular disease risk assessment
Paul Collinson
CURRENT OPINION IN CARDIOLOGY (2014)
High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort
Tanja Zeller et al.
EUROPEAN HEART JOURNAL (2014)
Comparison of Three Troponins as Predictors of Future Cardiovascular Events - Prospective Results from the FINRISK and BiomaCaRE Studies
Johannes Tobias Neumann et al.
PLOS ONE (2014)
High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men
Kai M. Eggers et al.
AMERICAN HEART JOURNAL (2013)
Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality
Oludamilola W. Oluleye et al.
ANNALS OF EPIDEMIOLOGY (2013)
Human cardiac troponin complex. Structure and functions
I. A. Katrukha
BIOCHEMISTRY-MOSCOW (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
CIRCULATION (2013)
Biomarkers of Chronic Cardiac Injury and Hemodynamic Stress Identify a Malignant Phenotype of Left Ventricular Hypertrophy in the General Population
Ian J. Neeland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population
Kai M. Eggers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cardiomyocyte Injury Assessed by a Highly Sensitive Troponin Assay and Sudden Cardiac Death in the Community The Cardiovascular Health Study
Ayman A. Hussein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cardiac troponin level elevations not related to acute coronary syndromes
Evangelos Giannitsis et al.
NATURE REVIEWS CARDIOLOGY (2013)
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress The Framingham Heart Study
Thomas J. Wang et al.
CIRCULATION (2012)
Increased Cardiac Troponin I As Measured by a High-Sensitivity Assay Is Associated with High Odds of Cardiovascular Death: The Minnesota Heart Survey
Fred S. Apple et al.
CLINICAL CHEMISTRY (2012)
Reference change values
Callum G. Fraser
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Prospective Associations of B-Type Natriuretic Peptide With Markers of Left Ventricular Function in Individuals With and Without Type 2 Diabetes An 8-year follow-up of the Hoorn Study
Maria H. Kroon et al.
DIABETES CARE (2012)
The paradox of low BNP levels in obesity
Aldo Clerico et al.
HEART FAILURE REVIEWS (2012)
Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP
Fima Macheret et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones
Aldo Clerico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Thomas J. Wang
CIRCULATION (2011)
Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies
Roman Pfister et al.
PLOS MEDICINE (2011)
Multiple risk factor interventions for primary prevention of coronary heart disease
Shah Ebrahim et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Cardiac troponin may be released by ischemia alone, without necrosis
Peter E. Hickman et al.
CLINICA CHIMICA ACTA (2010)
Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
James A. de Lemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Philip Greenland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Time to Treatment and Acute Coronary Syndromes: Bridging the Gap in Rapid Decision Making
W. Frank Peacock
REVIEWS IN CARDIOVASCULAR MEDICINE (2010)
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
Mark A. Hlatky et al.
CIRCULATION (2009)
The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: Proposal for a working hypothesis
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2009)
Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?
Alberto Giannoni et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Cardiac troponin-I and risk of heart failure: a community-based cohort study
Johan Sundstrom et al.
EUROPEAN HEART JOURNAL (2009)
Old and new biomarkers of heart failure
Michele Emdin et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
N-Terminal Pro-B-Type Natriuretic Peptide in Overweight and Obese Patients With and Without Diabetes: An Analysis Based on Body Mass Index and Left Ventricular Geometry
Seung Jei Park et al.
Korean Circulation Journal (2009)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure
Michele Emdin et al.
CLINICAL CHEMISTRY (2007)
Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy
Paola Belluardo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease - A meta-analysis
NA Khan et al.
CIRCULATION (2005)
Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease
T Mueller et al.
CLINICA CHIMICA ACTA (2004)
分享论文
